Shenxin Bio

深信生物

Shenxin Bio

Biotech/Healthcare

Deepin Biotech develops novel therapeutic vaccines and drugs, with a focus on biotechnology and medical technology R&D. Leveraging an internationally leading lipid nanoparticle (LNP) delivery platform, the company has built pipelines across four areas: rare diseases, therapeutic cancer vaccines…

Latest round: Series B (2022)

Source: ChinaBulls — chinabulls.com

Last updated 2022-03-01